Company / Cash per Share
Protagonist Therapeutics, Inc. Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$2.02
FY2025
5-year range
$1.49 / $3.29
FY2021-FY2025
Trend
+35.1%
vs FY2024
Sector context
#105 of 205
Health Care
What the data says
At $2.02, Protagonist Therapeutics, Inc.'s cash per share ranks #105 of 205 in the Health Care sector. Cash per Share has fluctuated over the past 10 years, ranging from $1.27 in FY2019 to $5.99 in FY2017.
Based on SEC 10-K filings.
2.02 in FY2025 with a 5-year CAGR of -10.0%.
Declined from $3.29 to $2.02 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -7.6%
- 5-Year CAGR
- -10.0%
- 10-Year CAGR
- -
Sector benchmark
#105 of 205 in Health CareTop 51% of 205This company $2.02 Sector average $72.93
▼
-97.2% below sector average
Key checks
Key Insights
- In FY2025, cash per share increased 35.1% year-over-year.
- Ranks #105 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2017.
- Lowest cash per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 4.66 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.02 | +35.1% |
| FY2024 | $1.49 | -54.6% |
| FY2023 | $3.29 | +28.3% |
| FY2022 | $2.56 | -4.0% |
| FY2021 | $2.67 | -21.8% |
| FY2020 | $3.41 | +167.7% |
| FY2019 | $1.27 | -65.3% |
| FY2018 | $3.68 | -38.6% |
| FY2017 | $5.99 | +84.8% |
| FY2016 | $3.24 | -79.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026